Opus Genetics

company

About

Opus Genetics is a gene therapy company for ultra-rare blinding conditions.

Details

Last Funding Type
Seed
Last Funding Money Raised
$19M
Industries
Health Care,Health Diagnostics,Wellness
Founded date
Jan 1, 2004
Operating Status
Active

Opus Genetics is a patient-first, science-driven gene therapy company tackling manufacturing obstacles standing in the way of treatments for ultra-rare blinding conditions.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$19M
Opus Genetics has raised a total of $19M in funding over 2 rounds. Their latest funding was raised on Sep 22, 2021 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 22, 2021 Seed $19M 1 Retinal Degeneration Fund Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Opus Genetics is funded by 1 investors. Retinal Degeneration Fund are the most recent investors.
Investor Name Lead Investor Funding Round
Retinal Degeneration Fund Yes Seed